The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab

Kristian Reich; Christopher Em Griffiths

doi:10.1007/s00403-008-0885-7

Back

The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab

Article 2008 en

Related publications

Article2006

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial

Kristian Reich, Frank O. Nestlé, Kim Papp, J.‐P. Ortonne, Yifang Wu, M Bala, Robert J. Evans, Cynthia Guzzo, Shuangyue Li, Lisa T. Dooley, Christopher Em Griffiths

Article2008

Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis.

Kristian Reich, Frank O. Nestlé, Ying Wu, Mohan Bala, D. Eisenberg, Cynthia Guzzo, Shu Li, Lisa T. Dooley, Christopher Em Griffiths

Article2010

Skin and Nail Responses after 1 Year of Infliximab Therapy in Patients with Moderate-to-Severe Psoriasis: A Retrospective Analysis of the EXPRESS Trial

Kristian Reich, Jean-Paul Ortonne, Urs Kerkmann, Yanxin Wang, J.‐H. Saurat, Kim Papp, Richard G. Langley, Christopher Em Griffiths

Article2007

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year

Phoebe Rich, Christopher Em Griffiths, Kristian Reich, Frank O. Nestlé, Richard K. Scher, Shu Li, Stephen Xu, Ming-Chun Hsu, Cynthia Guzzo

Article2022

Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure

Christopher Em Griffiths, Melinda Gooderham, Jean‐Frédéric Colombel, Tadashi Terui, Ana P. Accioly, Gaia Gallo, Danting Zhu, Andrew Blauvelt

The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab

Discussion(0)

Related publications

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial

Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis.

Skin and Nail Responses after 1 Year of Infliximab Therapy in Patients with Moderate-to-Severe Psoriasis: A Retrospective Analysis of the EXPRESS Trial

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year

Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure